Anti-diabetic drug sales soar in Kerala; medicines worth Rs 2,000 cr sold in 1 year 


In Kerala, cardiovascular drugs occupy first position in terms of sale, while anti-diabetic drugs are second in position. Also, diabetic complications are one of the major causes of heart diseases.  

Representative Image | Photo: Getty Image

Kannur: Sales of anti-diabetic drugs are soaring in Kerala. Reportedly, diabetic patients in the state bought medicines, including tablets and insulin, worth Rs 2,000 crores within one year.

As per reports, medicines worth Rs 15,000 crores were sold on an average during the last financial year and 15 per cent accounted for diabetic medicines.

In Kerala, cardiovascular drugs occupy the top position in terms of sale, while anti-diabetic drugs comes second. Also, diabetic complications are one of the major causes of heart diseases.

According to All Kerala Chemist and Druggist Association (AKCDA), the diabetic drug sales are increasing significantly each year.

In India, there has been a total sale of medicines worth Rs 1.76 lakh crore in the last year. There has been a rapid increase in sales since the last 10 years.

Apparently, two types of modern insulins, metformin+glimepiride, metformin+vildagliptin and metformin+sitagliptin are the top five selling drugs.


Add Comment
Related Topics

Get daily updates from Mathrubhumi.com

Youtube
Telegram
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.